A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We established a fluorescent in situ hybridization protocol for the detection of a persistent DNA virus genome within tissue sections of animal models. This protocol enables studying infection process by codetection of the viral genome, its RNA products, and viral or cellular proteins within single cells.
Single cell codetection of a gene, its RNA product and cellular regulatory proteins is critical to study gene expression regulation. This is a challenge in the field of virology; in particular for nuclear-replicating persistent DNA viruses that involve animal models for their study. Herpes simplex virus type 1 (HSV-1) establishes a life-long latent infection in peripheral neurons. Latent virus serves as reservoir, from which it reactivates and induces a new herpetic episode. The cell biology of HSV-1 latency remains poorly understood, in part due to the lack of methods to detect HSV-1 genomes in situ in animal models. We describe a DNA-fluorescent in situ hybridization (FISH) approach efficiently detecting low-copy viral genomes within sections of neuronal tissues from infected animal models. The method relies on heat-based antigen unmasking, and directly labeled home-made DNA probes, or commercially available probes. We developed a triple staining approach, combining DNA-FISH with RNA-FISH and immunofluorescence, using peroxidase based signal amplification to accommodate each staining requirement. A major improvement is the ability to obtain, within 10 µm tissue sections, low-background signals that can be imaged at high resolution by confocal microscopy and wide-field conventional epifluorescence. Additionally, the triple staining worked with a wide range of antibodies directed against cellular and viral proteins. The complete protocol takes 2.5 days to accommodate antibody and probe penetration within the tissue.
Herpes simplex virus type 1 (HSV-1) is a persistent human neurotropic virus, establishing a long-term latent infection in neurons of the trigeminal ganglia (TG) of the peripheral nervous system, from which it reactivates periodically to replicate and spread. The HSV-1 genome is a 150 kb dsDNA localizing in the nucleus of the host neuron where it remains as multicopy chromatinized plasmids, which do not integrate into the host-cell genome1,2. During latency, the HSV-1 replicative cycle genetic program is strongly repressed, and gene expression is restricted to the latency-associated transcript (LAT) locus, from latency establishment to initiation of reactivation3. LAT produces a long 8.5 kb noncoding RNA processed into a major 2 kb stable lariat, and several miRNA4-7. HSV-1 latency is thus characterized by the presence of the viral genomic DNA, LAT RNA, and the absence of detectable replicative cycle proteins.
Animal models, predominantly mouse and rabbit, are experimental models recapitulating several features of latency in human. One of the main interests of those models is that they allow studying physiological aspects of HSV-1 latency in immunocompetent hosts. Over the past decades, many experimental tools, such as genetically modified viruses and mice, have been developed to study the physiology, genetics, and cellular biology of HSV-1 latency, from animal tissues. Until now, viral genomic DNA was detected and quantified by Southern blot and qPCR from dissociated TGs. However, there is currently no method available to detect HSV-1 genome by in situ hybridization on tissue sections8. Consequently, latency is routinely assessed on histological sections through the detection of LAT RNA by RNA in situ hybridization rather than viral genome detection. Because it has been impossible to characterize infected cells based on the presence of viral genomes, this technical limitation has been a major drawback to the analysis of many aspects of the host-virus interactions, such as the relationship between the viral genome and cellular and viral gene expression or the host cell-mediated immune response9,10.
Most importantly, the cell-to-cell heterogeneity of the latent infection remains relatively unexplored and has been shown to be a key feature of latency in mice and in human sensory ganglion neurons implanted into SCID mice11-17. Typically, it was shown by qPCR that the HSV-1 genome copy number per cell varies from 5 to several hundreds. Although LAT appears as a key regulator of latency and reactivation, qPCR data on isolated neurons and in situ PCR indicated that only a subset of latently infected neurons, as low as 30%, expresses the LAT locus11,12,18-21. How the host cell and the cellular environment within the tissue impact on the virus latency establishment and viral gene expression remains unclear. Here we describe a robust fluorescent in situ hybridization (FISH) method for the efficient detection of low-copy HSV-1 genomic DNA within animal neuronal tissue sections. This method has been designed and used by us to get access to high resolution microscopy imaging that is necessary to study the interaction of the viral genome with the host cell intra-nuclear components22. Additionally, we describe a multiple staining method for the simultaneous detection of the viral DNA with RNA and proteins, which is a unique tool to describe the virus-host interactions that regulate viral gene expression. The method can also be applied for a broad range of analyses requiring the detection of HSV-1 latent genome, such as quantifying infected neurons in large number of sections. A key step is to apply antigen retrieval treatment to make the viral DNA accessible to hybridization. Thus, this protocol might also be efficient to the detection of other dsDNA viruses, which are currently not detectable by conventional DNA-FISH approaches within animal tissues.
This method was used in a study published previously 22. For general background and description of conventional manipulation on ISH, IF and FISH, we suggest the following available literature 23.
1. Animal Infection
All procedures involving experimental animals conformed to ethical issues from the Association for Research in Vision and Ophthalmology (ARVO) Statement for the use of animals in research, and were approved by the local Ethical Committee of UPR-3296-CNRS, in accordance with European Community Council Directive 86/609/EEC. All animals received unlimited access to food and water.
The method of mouse infection with HSV-1 described below has been used in studies previously published24-26.
2. Mouse Perfusion-fix
3. TG Harvesting
4. Cryosection Preparation
5. HSV-1 Probe Labeling
The protocol described hereafter for the detection of HSV-1 genome by DNA FISH has been successfully used with two types of probes. The first is a home-made Cy3-labeled fluorescent probe which is appropriate for the fine analysis of nuclear organization within individual cells, by high magnification fluorescent microscopy. The second is a commercially available biotinylated probe, which can be combined with peroxidase-based signal amplification to provide a bright signal. The latter is appropriate for identification and quantification of virus containing neurons at low magnification in whole section, and for the analysis of the HSV-1 genome patterns. End-users should evaluate which approach fits best the goal of their study. The commercially available probe is listed in the reagent section, and the preparation of the home-made probe is described below.
6. DNA-FISH
Figure 1 shows an overview of the main steps of the DNA-FISH protocol, and how to perform DNA-FISH as part of a multiple staining experiment to codetect RNA and protein, as described in Protocols 7-9.
7. Dual RNA-DNA FISH
See Figure 1, green boxes for an overview.
For multiple staining procedures including an RNA-FISH step, it is generally advised to first perform RNA detection as such target is sensitive to degradation by RNAse and chemicals. Additionally, DNA-FISH procedure includes treatments that reduce the efficiency of other staining. For RNA-FISH, we chose an enzyme based detection approach (Tyramide Signal Amplification (TSA) using biotinylated probes and peroxidase (HRP) coupled streptavidin). TSA is based on a fluorescent tyramide substrate (see reagent table for details), which is covalently linked to the tissue by a peroxidase enzymatic reaction. The RNA-FISH signal is thus preserved during DNA-FISH.
8. Immuno-DNA FISH
See Figure 1, purple boxes for an overview.
Similarly to RNA-DNA-FISH, it is advised to perform first the immunofluorescence, since DNA-FISH is likely to denature proteins and prevent their detection by antibodies. The quality of immunofluorescence signal is highly dependent on the antibody characteristics, and several antibodies should be tested whenever possible. Epitope unmasking is performed once before the immunofluorescence to improve both the protein detection and DNA-FISH. To preserve the immunofluorescence signal on the sample during the DNA-FISH procedure it is necessary to covalently link it to the tissue. We present here two approaches that provided good results in our hands, antibody post-fixation and tyramide based detection (see step 8.5). The choice should be driven by preliminary tests for each target/antibody pair.
9. Dual DNA-RNA FISH Coupled with Immunofluorescence
See Figure 1, orange boxes for an overview.
RNA-FISH is performed first, followed by immunofluorescence, and lastly DNA-FISH. If immunofluorescence is detected by tyramide reaction, it is key to quench completely the HRP activity from the RNA-FISH step with H2O2, and to verify that quenching is efficient. This is done by using one slide as a "no primary antibody" control.
Because ethanol-based dehydration is deleterious for some solvent-sensitive proteins, this step of RNA-FISH can inhibit immunofluorescence. If so, RNA-FISH can be performed with an alternate protocol, as detailed below in stpe 9.3.
10. Slide Mounting and Imaging
After several months of extensive testing, we discovered that heat-based chemical unmasking made latent HSV-1 genome available for fluorescent in situ hybridization. During the process, we tried various unmasking procedures, and only heat-based treatments (i.e. heating the sections up to sub-boiling temperature in a microwave oven) appeared efficient. We then tested several salt buffers that are routinely used in immunohistochemistry (IHC) and electron microscopy to retrieve epitopes31,32, in...
The protocol described here allows the detection of HSV-1 latent genome within neurons of mouse neuronal tissue sections. Our understanding of the pathways regulating viral gene expression has been limited by the lack of method to detect HSV-1 genomic DNA in situ within neuronal tissues. Information on genome copy number and proportion of infected neurons came mainly from PCR analysis on dissociated neurons11,12. In elucidating the role the host-cell nuclear architecture on HSV-1 latency, we set to de...
The authors declare no competing financial interests.
We thank N. Sawtell (Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA), S. Efstathiou (University of Cambridge, UK) and James Hill (LSU Health Sciences Center, New Orleans, USA) for providing samples from HSV-1-infected mice and rabbits, respectively, and for reagents; H. Masumoto (Kazusa DNA Research Institute, Chiba, Japan) and S. Khochbin (Institut Albert Bonniot, Grenoble, France) for helpful discussions.
This work was funded by grants from the Centre National de la Recherche Scientifique (CNRS) (ATIP program, to PL, http://www.cnrs.fr), the French National Research Agency (ANR) (ANR-05-MIIM-008-01, CENTROLAT, http://www.agencenationale-recherche.fr), the FINOVI Foundation (http://www.finovi.org/:fr:start), the LabEX DEVweCAN (ANR-10-LABX-61) of Université de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the ANR (http://www.agence-nationale-recherche.fr), l'Association pour la Recherche contre le Cancer (ARC-7979 and ARC-4910, http://www.arc-cancer.net), la Ligue Nationale Contre le Cancer (LNCC, http://www.ligue-cancer.net), and INCa (EPIPRO program, http://www.e-cancer.fr). FC and PL are CNRS researchers.
Name | Company | Catalog Number | Comments |
Balb/c mice | Janvier, France | 6 week-old females | |
HSV-1 strains | SC16 strain (wild type) | See Labetoule, M. et al. Invest. Ophthalmol. Vis. Sci 44, 217–225 (2003) for details on HSV-1 strain and virus stock preparation. | |
Ketamine hydrochloride | Sigma | K2753 | Intraperitoneal injection of a solution containing Ketamine (100mg/kg) and Xylazine (10mg/kg) |
Xylazine hydrochloride | Sigma | X1251 | |
Paraformaldehyde (PFA) | Sigma | 158127 | Suspend 4 g of PFA in 90 ml of water. Add 50 µl of 1N NaOH, and heat at 60 °C in a water bath with agitation. PFA dissolves in about 30 min. Add 10 ml of 10x PBS. This solution can be prepared in advance and stored at -20 °C in 5 ml tubes. Caution. Manipulate under a fume hood. |
Physiological Saline | Sigma | 07982-100TAB-F | |
1x PBS, pH 7.4 (sterile) | Life Technologies | 10010-015 | |
Sucrose | Sigma | 84100 | Prepare a 20% sucrose solution in 1x PBS. |
Cryosectionning embedding medium - Tissue-Tek OCT Compound | SAKURA | 4583 | |
Large vector DNA purification kit | Qiagen | 12462 | To purify Cosmid or BAC vector containing HSV-1 genome and store at -20 °C |
Nick translation kit | Roche Applied Sciences | 10 976 776 001 | |
Cy3-dCTP | GE Healthcare | PA53021 | Protect from light |
0.5 M EDTA | Sigma | E6758 | |
G50 Mini spin column | GE Healthcare | 27-5330-01 | |
Salmon sperm DNA 10 mg/ml | Invitrogen Life Technologies | 15632-011 | |
Ethanol molecular biology grade | Sigma | 87047 | Prepare a 70% solution |
Salmon sperm DNA | Invitrogen Life Technologies | 15632-011 | |
Formamid Molecular biology grade | Sigma | F9037 | Caution. Manipulate under fume hood. |
HSV-1 biotinylated commercial probe | Enzo Life Sciences | ENZ-40838 | |
ImmEdge hydrophobic pen | Vector Laboratories | H-4000 | |
20x Saline Sodium Citrate (SSC) | Sigma | S6639 | Prepare a 2x SSC solution in ddH20. |
Triton X-100 | Sigma | T8787 | Prepare a 10% stock solution in water and store at +4 °C. Prepare the 0.5% solution in 1x PBS right before use. |
10 mM Sodium citrate pH 6.0 | Sigma | S1804 | Prepare a 100 mM stock solution (10x). Weigh 10.5 g of citric acid (MW 210.14). Caution, irritant and toxic, wear appropriate mask and gloves), and dissolve in 400 ml water. Adjust pH at 6.0 with 1 N NaOH (caution, irritant, wear gloves). Adjust to 500 ml with distilled water. Dilute 10x in distilled water before use. |
Acetic Acid | Sigma | 320099 | |
Methanol, molecular biology grade | Sigma | 322415 | |
Dextran sulfate - MW 500,000 | Euromedex | EU0606-A | |
Denhardt's solution (100x) | Euromedex | 1020-A | |
Rubber Cement "FixoGum" | Marabut | 290110000 | |
DNA purification kit - Qiaquick PCR purification kit | Qiagen | 28104 | |
T7 in vitro transcription kit | Ambion Life Technologies | AM1314 | |
Biotin-16-UTP | Roche Applied Sciences | 11388908910 | |
RNA purification minicolumn | Qiagen | 73404 | |
Ribonucleoside Vanadyl Complex | New England Biolabs | S1402S | |
H2O2 | Sigma | H3410 | Prepare a 3% solution in distilled water. Store at +4 °C and protect from light. |
Yeast tRNA | Invitrogen | 15401011 | prepare a 10 mg/ml solution in RNAse free water |
Normal Goat Serum | Invitrogen | PCN5000 | |
Primary antibodies | any supplier | The following primary antibodies were used in the result section: anti-mouse CENP-A (rabbit mAb C51A7, Cell Signaling Technologies), and anti-ATRX H-300 (Santa Cruz Biotechnology) | |
Secondary fluorescent antibodies | Invitrogen Life Technologies | The fluorescent secondary antibodies routinely used in our protocol are Alexa Fluor labeled goat antibodies (IgG H+L). The antibody used in the result section is an anti-rabbit goat antibody labaled with Alexa Fluor 488 (reference A11001) | |
Tyramide Signal Amplification (TSA) kit - Streptavidin + Alexa Fluor 350 (blue fluorescence) | Invitrogen Life Technologies | #T20937 | TSA kits are also available from Perkin Elmer |
Tyramide Signal Amplification (TSA) kit - Streptavidin + Alexa Fluor 488 (green fluorescence) | Invitrogen Life Technologies | #T20932 | |
Hoechst 33342 | Invitrogen Life Technologies | H3570 | Prepare a 0.5 µg/ml solution in 1x PBS immediately before use. Discard the remaining solution. |
22 mm x 50 mm coverslip. n°1.5 glass | Electron Microscopy Sciences | 72204-04 | |
Mounting medium with anti-fading agent - VECASHIELD | Vector Laboratories | H-1000 | Another conventional product is Fluoromount G from Electron Microscopy Science |
Superfrost glass slides | FisherScientific | 12-550-15 | |
Equipment/Material | Company | Reference | Note |
Needle for infection | Glass micropipette hot drawn. Custom made. | ||
Dissection equipment | Moria, France | Microsurgical scissors and forceps | |
Peristaltic pump | Cole Palmer Instruments | Easyload Masterflex | |
Microsyringe pump device (Nano Pump) | kdScientific | KDS310 | |
Cryostat | Leica France | CM 1510-1 | |
-80 °C freezer | Sanyo | Ultra Low -80 °C | |
Domestic microwave oven | |||
Dry block heater | Eppendorf | 022670204 | |
Incubator Slide moat | Boekel Scientific | 240000 | |
Coplin Jar | Dominique Dutscher | 68512 | |
Staining glass container | Dominique Dutscher | 68506 | |
Fluorescent microscope | Zeiss | The images presented in the result section were collected with a Zeiss AxioObserver with objective 40X LD NeoFluor N.A 0.6, and 100X PlanApochromat N.A 1.3. Filter set #38, #43, and #43. HXP 120 fluorescence light source. Photometrics CoolSNAP HQ2 CCD camera. Signal will be more easily observed on a recent high efficiency microscope such as Zeiss AxioImager/AxioObserver series, Nikon Ti-E/Ni-E series or Leica DM/DMI6000 series |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved